Onset of Action for Oral Digoxin
Oral digoxin begins to take effect within 0.5 to 2 hours after administration, with peak therapeutic effects occurring between 2 to 6 hours. 1
Pharmacokinetic Timeline
Initial Onset
- The onset of pharmacologic effect occurs 0.5-2 hours after oral administration, as documented for ventricular response rate in atrial fibrillation, inotropic effects, and electrocardiographic changes. 1
- Digoxin appears early in the blood after oral administration, with peak portal-peripheral concentration differences occurring at approximately 18 minutes in absorption studies. 2
Peak Effect
- Peak therapeutic effects are achieved 2-6 hours after oral dosing, representing the time when maximum clinical benefit is observed. 1
- The mean peak serum concentration after oral solution administration reaches approximately 2.0 ng/ml. 3
Absorption Characteristics
- Approximately 70-80% of an oral dose is absorbed, primarily in the proximal small intestine. 4
- About two-thirds of the oral dose is absorbed within 6 hours after administration. 2
- The mean peak absorption rate corresponds to an absorption half-time of 0.78 hours. 2
Important Clinical Caveats
Delayed Therapeutic Effect for Rate Control
- When using intravenous digoxin for rate control in atrial fibrillation, there is a delay of at least 60 minutes before onset of therapeutic effect in most patients, with peak effect not developing for up to 6 hours. 5
- This delay reflects the time needed for digoxin to reach its site of action and achieve equilibrium between serum and tissue concentrations. 1
Distribution vs. Therapeutic Effect
- Early high serum concentrations do not reflect the concentration of digoxin at its site of action; steady-state post-distribution serum concentrations are in equilibrium with tissue concentrations and correlate with pharmacologic effects. 1
- Digoxin is extensively distributed in tissues with a large apparent volume of distribution, meaning blood levels initially do not predict clinical effect. 1, 4
Clinical Implications for Rate Control
- Digoxin is no longer considered first-line therapy for rapid management of atrial fibrillation due to this delayed onset and reduced efficacy in high sympathetic tone states. 5
- For acute rate control, beta-blockers or calcium channel blockers (verapamil, diltiazem) are preferred as they act more rapidly. 5